secwatch / observer
8-K filed December 29, 2023, 6:59 PM ET ticker KFS CIK 0001072627
M&A confidence high sentiment negative materiality 0.65

Kingsway terminates acquisition agreement for National Institute of Clinical Research due to seller breaches

KINGSWAY FINANCIAL SERVICES INC

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

KINGSWAY FINANCIAL SERVICES INC terminated Membership Interest Purchase Agreement with National Institute of Clinical Research Inc. and Dr. Sali Aswad valued at Termination of Membership Interest Purchase Agreement (effective 2023-12-23).

Action
termination
Agreement
equity purchase
Counterparty
National Institute of Clinical Research Inc. and Dr. Sali Aswad
Value
Termination of Membership Interest Purchase Agreement
Effective
2023-12-23
Exact text from the filing
Item 1.02. Termination of a Material Definitive Agreement. As previously disclosed, on October 19, 2023, Kingsway Search Xcelerator Inc. (“Kingsway Buyer”), a subsidiary of Kingsway Financial Services Inc. (the “Company”), entered into a Membership Interest Purchase Agreement (the “Agreement”) with National Institute of Clinical Research Inc. (the “Seller”) and Dr. Sali Aswad (the “Shareholder”). On December 23, 2023, Kingsway Buyer delivered written notice to the Seller and the Shareholder that effective immediately it has terminated the Agreement as a result of the Seller’s and the Shareholder’s uncured breaches of certain representations, warranties, covenants and agreements and the resulting inability of the Seller and the Shareholder to satisfy the conditions to Kingsway Buyer’s obligation to consummate the transactions contemplated by the Agreement.
View on SEC.gov

239 material agreements filed in the last 30 days. Browse all material agreements →

KINGSWAY FINANCIAL SERVICES INC filing history →

Source: SEC EDGAR
accession 0001437749-23-035570
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.